Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Shares Repurchased (2020 - 2024)

Integra Lifesciences Holdings' Shares Repurchased history spans 5 years, with the latest figure at $2.5 million for Q4 2024.

  • For Q4 2024, Shares Repurchased changed N/A year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, down 95.29%, while the annual FY2025 figure was $221000.0, 99.58% down from the prior year.
  • Shares Repurchased for Q4 2024 was $2.5 million at Integra Lifesciences Holdings, down from $50.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $150.0 million in Q1 2023 and bottomed at $2.5 million in Q4 2024.
  • The 4-year median for Shares Repurchased is $112.5 million (2020), against an average of $92.1 million.
  • The largest YoY upside for Shares Repurchased was 20.0% in 2023 against a maximum downside of 20.0% in 2023.
  • A 4-year view of Shares Repurchased shows it stood at $100.0 million in 2020, then increased by 25.0% to $125.0 million in 2022, then changed by 0.0% to $125.0 million in 2023, then tumbled by 98.02% to $2.5 million in 2024.
  • Per Business Quant, the three most recent readings for IART's Shares Repurchased are $2.5 million (Q4 2024), $50.0 million (Q2 2024), and $125.0 million (Q3 2023).